Tarin L. Clay
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Tarin L. Clay has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
- Elisabeth Callen
National Research Network, American Academy of Family Physicians, Leawood, KS, United States
7 shared publications - Melissa K. Filippi
National Research Network, American Academy of Family Physicians, Leawood, KS, United States
4 shared publications - Andrea Nederveld
Department of Family Medicine, University of Colorado School of Medicine, Aurora, USA
3 shared publications - Christina M. Hester
DARTNet Institute and American Academy of Family Physicians National Research Network, Aurora, Colorado, United States of America
3 shared publications - Elise Robertson
National Research Network, American Academy of Family Physicians, Leawood, KS, United States
3 shared publications - Angela M. Lanigan
National Research Network, American Academy of Family Physicians, Leawood, KS, United States
2 shared publications
Latest Publications
- Open Access
Delay discounting and low-value care decision-making by primary care clinicians in a survey-based vignette experiment
Introduction: Primary care clinicians (PCC) commonly make decisions in the context of time delay and uncertainty. Delay discounting (DD) and probability discounting (PD) are cognitive biases related to delay and uncertainty that are minimally explored in PCC. We assessed DD and PD in PCC and evaluated their association with low-value care (LVC) decision-making. Methods: We administered a survey to PCC in a Southeastern U.S health system and within the American Academy of Family Physicians networks. The survey comprised standardized psychometric assessments of DD and PD and four LVC clinical vignettes. Outcomes included DD and PD discounting rates for two monetary rewards ($100 and $10,000) and ratings of LVC likelihood (0-100). We used regression analysis with model selection to evaluate the relationship between variables. Results: 225 PCC (89% physicians, 11% advanced practice providers) participated. Heterogeneity in DD and PD rates was observed. For the $10,000 reward, ln k(DD)= -6.80, IQR:-7.60--6.10) and ln h(PD)= 1.75, IQR:1.75-2.36). The reward amount impacted DD and PD in opposing directions (i.e., lower DD/higher PD rates for $10,000 vs. $100). LVC likelihood was highest for low-value antibiotics and lowest for low-value cervical cancer screening (median 20, IQR:10-40 and 0, IQR:0-10, respectively). Model selection revealed demographic associations with LVC likelihood, but no association with DD or PD. Conclusions: Consistent with effects previously reported in non-clinicians, PCC exhibited a range of DD and PD, which ranged by reward magnitude. Neither DD nor PD predicted vignette-based LVC likelihood. Further research should investigate actual clinical practice patterns and other LVC scenarios.
Open AccessDelay discounting and low-value care decision-making by primary care clinicians in a survey-based vignette experiment
Introduction: Primary care clinicians (PCC) commonly make decisions in the context of time delay and uncertainty. Delay discounting (DD) and probability discounting (PD) are cognitive biases related to delay and uncertainty that are minimally explored in PCC. We assessed DD and PD in PCC and evaluated their association with low-value care (LVC) decision-making. Methods: We administered a survey to PCC in a Southeastern U.S health system and within the American Academy of Family Physicians networks. The survey comprised standardized psychometric assessments of DD and PD and four LVC clinical vignettes. Outcomes included DD and PD discounting rates for two monetary rewards ($100 and $10,000) and ratings of LVC likelihood (0-100). We used regression analysis with model selection to evaluate the relationship between variables. Results: 225 PCC (89% physicians, 11% advanced practice providers) participated. Heterogeneity in DD and PD rates was observed. For the $10,000 reward, ln k(DD)= -6.80, IQR:-7.60--6.10) and ln h(PD)= 1.75, IQR:1.75-2.36). The reward amount impacted DD and PD in opposing directions (i.e., lower DD/higher PD rates for $10,000 vs. $100). LVC likelihood was highest for low-value antibiotics and lowest for low-value cervical cancer screening (median 20, IQR:10-40 and 0, IQR:0-10, respectively). Model selection revealed demographic associations with LVC likelihood, but no association with DD or PD. Conclusions: Consistent with effects previously reported in non-clinicians, PCC exhibited a range of DD and PD, which ranged by reward magnitude. Neither DD nor PD predicted vignette-based LVC likelihood. Further research should investigate actual clinical practice patterns and other LVC scenarios.
- Open Access
- 6 May 2026
- Published by JMIR Publications Inc. in JMIR Formative Research
- Vol. 10, e71662
Comparing Usual Care With Coordinated Clinician and Patient Use of Mobile Technology in Primary Care for Patients With Major Depressive Disorder: Practice-Based Pilot Study
Background: Major depressive disorder (MDD) affects millions of Americans each year and is often diagnosed and treated in primary care. Evidence shows that self-management techniques, shared decision-making (SDM), and goal setting are effective strategies for managing MDD, but the required collaboration between patients and primary care clinicians can be difficult. Primary Care Path is a program for supporting depression management in primary care that includes a patient-facing mobile app and an accompanying care team–facing web interface. Leveraging programs that provide clinician-facing software with companion patient-facing mobile technology may help patients and physicians align depression treatment and management goals, support effective SDM, alleviate barriers, and improve both clinical care and patient outcomes. Objective: To pilot-test the use of Primary Care Path for MDD management in primary care and evaluate the impact of its use on depression treatment, symptoms, goal setting and attainment, and SDM. Methods: Four primary care clinical practices in the United States were assigned to program use (2 practices; intervention) versus usual care (2 practices; control). Intervention practices used the Primary Care Path program in their clinics and engaged patient participants in app use for 18 weeks. Clinical care teams engaged with the patient-informed program portal primarily during patient encounters (in-person, virtual or calls). Patient participants were smartphone users aged 18 years and older who were being treated for MDD. Patient participants received online surveys (medication changes, Patient Health Questionnaire-9 [PHQ-9], goal setting and attainment questions, and Shared Decision-Making Questionnaire-9 [SDM-Q-9]) at baseline, 6, 12, and 18 weeks. Results: A total of 76 patient participants (34 intervention; 42 control) were enrolled; the majority were female (27/34, 79%; 32/42, 76%), White (31/34, 91%; 40/42, 95%), non-Hispanic/Latino/a (29/34, 85%; 40/40, 100%), and employed (26/34, 77%; 34/42, 81%). Control patient participants’ conversations with their medical providers increased over the study period, while intervention patient conversations with their medical providers decreased over time. At week 18, intervention participants felt more successful than control in achieving their personalized treatment goals. More intervention patient participants initiated antidepressant medication by weeks 12 ( P =.03) and 18 ( P =.04) and switched medications by weeks 6 ( P =.009) and 12 ( P =.04) versus control. All patient participants demonstrated significant improvement in PHQ-9 scores throughout the study period ( P <.001), with no difference in change by group. Clinicians and patients indicated using the program to support SDM, but no significant differences were observed in SDM-Q-9 between intervention and control. Conclusions: Preliminarily, the use of this digital health program related to earlier medication optimization, earlier conversations between patients and medical providers, and patient attainment of goals that matter most to them, indicating that coordinated use of the program by both patients and clinical team members may enhance MDD management in primary care clinical settings.
- 6 May 2026
- Published by JMIR Publications Inc. in JMIR Formative Research
- Vol. 10, e71662
Open AccessComparing Usual Care With Coordinated Clinician and Patient Use of Mobile Technology in Primary Care for Patients With Major Depressive Disorder: Practice-Based Pilot Study
Background: Major depressive disorder (MDD) affects millions of Americans each year and is often diagnosed and treated in primary care. Evidence shows that self-management techniques, shared decision-making (SDM), and goal setting are effective strategies for managing MDD, but the required collaboration between patients and primary care clinicians can be difficult. Primary Care Path is a program for supporting depression management in primary care that includes a patient-facing mobile app and an accompanying care team–facing web interface. Leveraging programs that provide clinician-facing software with companion patient-facing mobile technology may help patients and physicians align depression treatment and management goals, support effective SDM, alleviate barriers, and improve both clinical care and patient outcomes. Objective: To pilot-test the use of Primary Care Path for MDD management in primary care and evaluate the impact of its use on depression treatment, symptoms, goal setting and attainment, and SDM. Methods: Four primary care clinical practices in the United States were assigned to program use (2 practices; intervention) versus usual care (2 practices; control). Intervention practices used the Primary Care Path program in their clinics and engaged patient participants in app use for 18 weeks. Clinical care teams engaged with the patient-informed program portal primarily during patient encounters (in-person, virtual or calls). Patient participants were smartphone users aged 18 years and older who were being treated for MDD. Patient participants received online surveys (medication changes, Patient Health Questionnaire-9 [PHQ-9], goal setting and attainment questions, and Shared Decision-Making Questionnaire-9 [SDM-Q-9]) at baseline, 6, 12, and 18 weeks. Results: A total of 76 patient participants (34 intervention; 42 control) were enrolled; the majority were female (27/34, 79%; 32/42, 76%), White (31/34, 91%; 40/42, 95%), non-Hispanic/Latino/a (29/34, 85%; 40/40, 100%), and employed (26/34, 77%; 34/42, 81%). Control patient participants’ conversations with their medical providers increased over the study period, while intervention patient conversations with their medical providers decreased over time. At week 18, intervention participants felt more successful than control in achieving their personalized treatment goals. More intervention patient participants initiated antidepressant medication by weeks 12 ( P =.03) and 18 ( P =.04) and switched medications by weeks 6 ( P =.009) and 12 ( P =.04) versus control. All patient participants demonstrated significant improvement in PHQ-9 scores throughout the study period ( P <.001), with no difference in change by group. Clinicians and patients indicated using the program to support SDM, but no significant differences were observed in SDM-Q-9 between intervention and control. Conclusions: Preliminarily, the use of this digital health program related to earlier medication optimization, earlier conversations between patients and medical providers, and patient attainment of goals that matter most to them, indicating that coordinated use of the program by both patients and clinical team members may enhance MDD management in primary care clinical settings.
- 23 February 2026
- Published by Wiley in The American Journal on Addictions
- Vol. 35 (4) , 525-533
Primary care's most pressing needs to address opioid use disorder: A qualitative study
Background and Objectives: Although buprenorphine is effective and approved for treating opioid use disorder (OUD), it remains underutilized in primary care settings. This study's objective was to explore what primary care teams need to overcome barriers in treating OUD, and to assess whether those needs change after receiving education on OUD treatment. Methods: The American Academy of Family Physicians hosted a 12‐month Project ECHO® educational series on OUD for primary care teams. Thematic analysis was conducted on participant responses pre‐ and post‐series to the survey item “Please list your most pressing needs related to OUD” ( N = 92). Results: Ninety‐two participants from 25 primary care practices from the US and Canada responded to the pressing needs item across both surveys. The most prevalent need reported at baseline was Education and Training, which became second to Health System Resources at endpoint. Respondents cited organizational protocols for OUD treatment as a pressing need among other Health System Resources such as support for reimbursement. Needs relating to transportation and housing; engaging patients to start and continue in OUD treatment; and addressing stigma within the community and health system were indicative of overlapping barriers. Discussion and Conclusions: Responses from primary care teams echo previous studies on barriers to OUD treatment and provide specific, actionable insight to addressing these barriers. Scientific Significance: Actionable insights, for example, implementing health system‐level OUD protocols and guidelines and promoting availability of OUD treatment and education, are ways that primary care teams could increase treatment of patients with OUD.
- 23 February 2026
- Published by Wiley in The American Journal on Addictions
- Vol. 35 (4) , 525-533
Primary care's most pressing needs to address opioid use disorder: A qualitative study
Background and Objectives: Although buprenorphine is effective and approved for treating opioid use disorder (OUD), it remains underutilized in primary care settings. This study's objective was to explore what primary care teams need to overcome barriers in treating OUD, and to assess whether those needs change after receiving education on OUD treatment. Methods: The American Academy of Family Physicians hosted a 12‐month Project ECHO® educational series on OUD for primary care teams. Thematic analysis was conducted on participant responses pre‐ and post‐series to the survey item “Please list your most pressing needs related to OUD” ( N = 92). Results: Ninety‐two participants from 25 primary care practices from the US and Canada responded to the pressing needs item across both surveys. The most prevalent need reported at baseline was Education and Training, which became second to Health System Resources at endpoint. Respondents cited organizational protocols for OUD treatment as a pressing need among other Health System Resources such as support for reimbursement. Needs relating to transportation and housing; engaging patients to start and continue in OUD treatment; and addressing stigma within the community and health system were indicative of overlapping barriers. Discussion and Conclusions: Responses from primary care teams echo previous studies on barriers to OUD treatment and provide specific, actionable insight to addressing these barriers. Scientific Significance: Actionable insights, for example, implementing health system‐level OUD protocols and guidelines and promoting availability of OUD treatment and education, are ways that primary care teams could increase treatment of patients with OUD.
- Open Access
- 29 January 2026
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 28 (1) , e72003
Patient and Care Team Perspectives of Barriers to and Facilitators for the Implementation of a Digital Health Program for Depression in Primary Care: Qualitative Study
Background: Depression is pervasive, and rates are rising in the United States. Most people with depression receive care from primary care clinicians, but gaps in the quality of care exist. Team-based approaches to depression care have been shown to aid in treatment and management; yet, challenges exist in implementation. Digital health apps have been shown to be effective in improving depression symptoms and enhancing patient engagement in some populations. Many, however, do not share data with clinical care teams. Objective: This study aimed to understand the barriers to and facilitators for implementation of a digital health program that supports coordinated use by clinical care teams and patients, via a mobile app and care team–facing web interface, for depression in primary care. Methods: This study was part of a larger intervention study that included 4 primary care practices: 2 intervention and 2 control sites. The intervention sites used a patient-facing mobile app and a care team–facing web interface, and the control sites continued usual care. The study team conducted interviews from May to October 2021. Patient and care team participants were recruited toward the end of their study involvement. Separate semistructured interview guides were developed for patient and care team participants. Interviews were recorded and transcribed. Data were coded using Atlas.ti.9, and data analysis was completed using a grounded theory approach. Results: Interviews with patient (n=8) and care team (n=8) participants revealed 3 main topics for program implementation: app/interface usability, tracking, and program recommendations. For app/interface usability, overall, navigation for both patient and care team participants was simple and straightforward. Although app content was relevant, patient participants desired additional educational resources and information to aid in their depression treatment and management. In terms of tracking, care team participants indicated that data obtained via the interface enabled them to monitor patients in between visits; and in some circumstances, these data facilitated conversations with patients about treatment plans. Tracking medication adherence differed among patient participants due to established routines of taking medications consistently, lack of motivation to track, or lack of interest in tracking. Care team participants reported the ability to respond more quickly to side effects. Patients commented on tracking difficulties: confusing response options, insufficient goal attainment response options, not being able to provide details or write notes, and no ability to change goals. Some patient and care team participants perceived that tracking encouraged communication with one another; others perceived tracking as having no impact on shared decision-making. Conclusions: Results suggest implementation of a digital health program for depression treatment and management in primary care practices could impact patient medication adherence, produce faster turnaround time for medication optimization, encourage goal setting, and foster communication between patients and care team members. Program enhancements could optimize patient and care team member engagement.
- 29 January 2026
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 28 (1) , e72003
Open AccessPatient and Care Team Perspectives of Barriers to and Facilitators for the Implementation of a Digital Health Program for Depression in Primary Care: Qualitative Study
Background: Depression is pervasive, and rates are rising in the United States. Most people with depression receive care from primary care clinicians, but gaps in the quality of care exist. Team-based approaches to depression care have been shown to aid in treatment and management; yet, challenges exist in implementation. Digital health apps have been shown to be effective in improving depression symptoms and enhancing patient engagement in some populations. Many, however, do not share data with clinical care teams. Objective: This study aimed to understand the barriers to and facilitators for implementation of a digital health program that supports coordinated use by clinical care teams and patients, via a mobile app and care team–facing web interface, for depression in primary care. Methods: This study was part of a larger intervention study that included 4 primary care practices: 2 intervention and 2 control sites. The intervention sites used a patient-facing mobile app and a care team–facing web interface, and the control sites continued usual care. The study team conducted interviews from May to October 2021. Patient and care team participants were recruited toward the end of their study involvement. Separate semistructured interview guides were developed for patient and care team participants. Interviews were recorded and transcribed. Data were coded using Atlas.ti.9, and data analysis was completed using a grounded theory approach. Results: Interviews with patient (n=8) and care team (n=8) participants revealed 3 main topics for program implementation: app/interface usability, tracking, and program recommendations. For app/interface usability, overall, navigation for both patient and care team participants was simple and straightforward. Although app content was relevant, patient participants desired additional educational resources and information to aid in their depression treatment and management. In terms of tracking, care team participants indicated that data obtained via the interface enabled them to monitor patients in between visits; and in some circumstances, these data facilitated conversations with patients about treatment plans. Tracking medication adherence differed among patient participants due to established routines of taking medications consistently, lack of motivation to track, or lack of interest in tracking. Care team participants reported the ability to respond more quickly to side effects. Patients commented on tracking difficulties: confusing response options, insufficient goal attainment response options, not being able to provide details or write notes, and no ability to change goals. Some patient and care team participants perceived that tracking encouraged communication with one another; others perceived tracking as having no impact on shared decision-making. Conclusions: Results suggest implementation of a digital health program for depression treatment and management in primary care practices could impact patient medication adherence, produce faster turnaround time for medication optimization, encourage goal setting, and foster communication between patients and care team members. Program enhancements could optimize patient and care team member engagement.
- 22 April 2024
- Published by Oxford University Press (OUP) in Family Practice
- Vol. 41 (5) , 702-710
Building physician wellness into the culture: evaluating a family physician well-being programme using the physician wellness inventory
Family physicians have a higher incidence of burnout, dissatisfaction, and disengagement compared to other medical specialties. Addressing burnout on the individual and systemic level is important to promoting wellness and preventing deleterious effects on physicians and patients. We used the Physician Wellness Inventory (PWI) to assess the effects of a wellness programme designed to equip family physicians with skills to address burnout. The PWI is a fourteen-item 5-point Likert scale broken down into 3 scores; (i) career purpose, (ii) cognitive flexibility, and (iii) distress. The PWI was distributed to a cohort of n = 111 family physician scholars at 3 time points: January 2021, May–June 2021, and October 2021. The response rate was 96.4% at baseline, and 72.1% overall. Demographic information was collected to assess differences. The survey was distributed online through Qualtrics (Provo, UT). Cognitive Flexibility scores at the endpoint were higher for POC scholars than white scholars (P = 0.024). Distress scores for all groups decreased over time. Female scholars were more nervous, and anxious at the start than male scholars (P = 0.012), which decreased over time (P = 0.022). New career scholars were more likely than later career scholars to be distressed (P = 0.007), but both groups’ distress decreased over time (P = 0.003). Later career scholars’ feelings of being bothered by little interest or pleasure in doing things decreased more than new career scholars (endpoint: P = 0.022; overall: P = 0.023). The wellness programme shows improvement in PWI scores, indicating the programme content should be evaluated further for system level improvements.
- 22 April 2024
- Published by Oxford University Press (OUP) in Family Practice
- Vol. 41 (5) , 702-710
Building physician wellness into the culture: evaluating a family physician well-being programme using the physician wellness inventory
Family physicians have a higher incidence of burnout, dissatisfaction, and disengagement compared to other medical specialties. Addressing burnout on the individual and systemic level is important to promoting wellness and preventing deleterious effects on physicians and patients. We used the Physician Wellness Inventory (PWI) to assess the effects of a wellness programme designed to equip family physicians with skills to address burnout. The PWI is a fourteen-item 5-point Likert scale broken down into 3 scores; (i) career purpose, (ii) cognitive flexibility, and (iii) distress. The PWI was distributed to a cohort of n = 111 family physician scholars at 3 time points: January 2021, May–June 2021, and October 2021. The response rate was 96.4% at baseline, and 72.1% overall. Demographic information was collected to assess differences. The survey was distributed online through Qualtrics (Provo, UT). Cognitive Flexibility scores at the endpoint were higher for POC scholars than white scholars (P = 0.024). Distress scores for all groups decreased over time. Female scholars were more nervous, and anxious at the start than male scholars (P = 0.012), which decreased over time (P = 0.022). New career scholars were more likely than later career scholars to be distressed (P = 0.007), but both groups’ distress decreased over time (P = 0.003). Later career scholars’ feelings of being bothered by little interest or pleasure in doing things decreased more than new career scholars (endpoint: P = 0.022; overall: P = 0.023). The wellness programme shows improvement in PWI scores, indicating the programme content should be evaluated further for system level improvements.
- 11 April 2024
- Published by Taylor & Francis in Journal of Addictive Diseases
- Vol. 43 (1) , 59-66
Quantifying diagnosis and treatment practices of opioid use disorder in primary care practices using chart review data
In 2021, opioid overdose deaths reached 80,411 in the United States, an increase of 15% from the prior year1,2. An estimated 3.3% of individuals aged 12 or older, roughly 9.2 million people in the ...
- 11 April 2024
- Published by Taylor & Francis in Journal of Addictive Diseases
- Vol. 43 (1) , 59-66
Quantifying diagnosis and treatment practices of opioid use disorder in primary care practices using chart review data
In 2021, opioid overdose deaths reached 80,411 in the United States, an increase of 15% from the prior year1,2. An estimated 3.3% of individuals aged 12 or older, roughly 9.2 million people in the ...
- 23 May 2023
- Published by Oxford University Press (OUP) in Family Practice
- Vol. 41 (3) , 277-282
Migraine care practices in primary care: results from a national US survey
Background: Primary care clinicians play a critical role in diagnosis and treatment of migraine, yet barriers exist. This national survey assessed barriers to diagnosis and treatment of migraine, preferred approaches to receiving migraine education, and familiarity with recent therapeutic innovations. Methods: The survey was created by the American Academy of Family Physicians (AAFP) and Eli Lilly and Company and distributed to a national sample through the AAFP National Research Network and affiliated PBRNs from mid-April through the end of May 2021. Initial analyses were descriptive statistics, ANOVAs, and Chi-Square tests. Individual and multivariate models were completed for: adult patients seen in a week; respondent years since residency; and adult patients with migraine seen in a week. Results: Respondents who saw fewer patients were more likely to indicate unclear patient histories were a barrier to diagnosing. Respondents who saw more patients with migraine were more likely to indicate the priority of other comorbidities and insufficient time were barriers to diagnosing. Respondents who had been out of residency longer were more likely to change a treatment plan due to attack impact, quality of life, and medication cost. Respondents who had been out of residency shorter were more likely to prefer to learn from migraine/headache research scientists and use paper headache diaries. Conclusions: Results demonstrate differences in familiarity with migraine diagnosis and treatment options based on patients seen and years since residency. To maximise appropriate diagnosis within primary care, targeted efforts to increase familiarity and decrease barriers to migraine care should be implemented.
- 23 May 2023
- Published by Oxford University Press (OUP) in Family Practice
- Vol. 41 (3) , 277-282
Migraine care practices in primary care: results from a national US survey
Background: Primary care clinicians play a critical role in diagnosis and treatment of migraine, yet barriers exist. This national survey assessed barriers to diagnosis and treatment of migraine, preferred approaches to receiving migraine education, and familiarity with recent therapeutic innovations. Methods: The survey was created by the American Academy of Family Physicians (AAFP) and Eli Lilly and Company and distributed to a national sample through the AAFP National Research Network and affiliated PBRNs from mid-April through the end of May 2021. Initial analyses were descriptive statistics, ANOVAs, and Chi-Square tests. Individual and multivariate models were completed for: adult patients seen in a week; respondent years since residency; and adult patients with migraine seen in a week. Results: Respondents who saw fewer patients were more likely to indicate unclear patient histories were a barrier to diagnosing. Respondents who saw more patients with migraine were more likely to indicate the priority of other comorbidities and insufficient time were barriers to diagnosing. Respondents who had been out of residency longer were more likely to change a treatment plan due to attack impact, quality of life, and medication cost. Respondents who had been out of residency shorter were more likely to prefer to learn from migraine/headache research scientists and use paper headache diaries. Conclusions: Results demonstrate differences in familiarity with migraine diagnosis and treatment options based on patients seen and years since residency. To maximise appropriate diagnosis within primary care, targeted efforts to increase familiarity and decrease barriers to migraine care should be implemented.
- Open Access
- 1 April 2022
- Published by Annals of Family Medicine
- Vol. 20 (Supplement) , 2744
Telehealth in the pandemic: Experiences and perspectives of primary care clinicians
Context: Use of telehealth services increased dramatically during the COVID-19 pandemic across a variety of medical specialties including primary care. While multiple surveys have tracked changes in the use of telehealth services across phases of the pandemic, few qualitative studies have explored primary care clinicians’ experiences with and perceptions of telehealth services during this time. Objective: This study examined the immediate and long-term effects of COVID-19 on primary care clinicians use of telehealth services including challenges and benefits. Study Design: Qualitative study. Setting: AAFP National Research Network staff virtually conducted semi-structured, open-ended interviews with primary care clinicians between August 7, 2020 and September 1, 2020. Outcome Measures: Primary care clinicians’ perceptions of and experiences with telehealth services during the COVID-19 pandemic. Results: 26 primary care clinicians from a variety of practice and geographic settings participated in the study. Clinicians reported a mix of positive and negative experiences with telehealth during the COVID-19 pandemic across four domains: 1) adoption of telehealth, 2) billing of telehealth services, 3) patient experiences with telehealth, 4) telehealth efficacy. Due to their institutional support, clinicians affiliated with healthcare systems tended to have more positive experiences with adoption and billing of telehealth services. Clinicians in rural communities discussed the nuanced impact of telehealth in reducing barriers to care (e.g., transportation), while introducing additional barriers (e.g., telehealth compatible devices and stable broadband access). Some clinicians spoke to the value of telehealth for primary care visits which involve chronic disease management, while others felt it compromised tenets of primary care such as in-person examination. Conclusions: Primary care clinicians’ perspectives of and experiences with telehealth during the COVID-19 pandemic provide critical insight needed to prepare for future crises affecting access to healthcare. As telehealth services advance, independent clinicians may require additional support to ensure they are capable of meeting patient needs through virtual care modalities. Furthermore, any effort to increase telehealth support for clinicians should be accompanied by initiatives to address barriers to telehealth for rural, underserved communities.
- 1 April 2022
- Published by Annals of Family Medicine
- Vol. 20 (Supplement) , 2744
Open AccessTelehealth in the pandemic: Experiences and perspectives of primary care clinicians
Context: Use of telehealth services increased dramatically during the COVID-19 pandemic across a variety of medical specialties including primary care. While multiple surveys have tracked changes in the use of telehealth services across phases of the pandemic, few qualitative studies have explored primary care clinicians’ experiences with and perceptions of telehealth services during this time. Objective: This study examined the immediate and long-term effects of COVID-19 on primary care clinicians use of telehealth services including challenges and benefits. Study Design: Qualitative study. Setting: AAFP National Research Network staff virtually conducted semi-structured, open-ended interviews with primary care clinicians between August 7, 2020 and September 1, 2020. Outcome Measures: Primary care clinicians’ perceptions of and experiences with telehealth services during the COVID-19 pandemic. Results: 26 primary care clinicians from a variety of practice and geographic settings participated in the study. Clinicians reported a mix of positive and negative experiences with telehealth during the COVID-19 pandemic across four domains: 1) adoption of telehealth, 2) billing of telehealth services, 3) patient experiences with telehealth, 4) telehealth efficacy. Due to their institutional support, clinicians affiliated with healthcare systems tended to have more positive experiences with adoption and billing of telehealth services. Clinicians in rural communities discussed the nuanced impact of telehealth in reducing barriers to care (e.g., transportation), while introducing additional barriers (e.g., telehealth compatible devices and stable broadband access). Some clinicians spoke to the value of telehealth for primary care visits which involve chronic disease management, while others felt it compromised tenets of primary care such as in-person examination. Conclusions: Primary care clinicians’ perspectives of and experiences with telehealth during the COVID-19 pandemic provide critical insight needed to prepare for future crises affecting access to healthcare. As telehealth services advance, independent clinicians may require additional support to ensure they are capable of meeting patient needs through virtual care modalities. Furthermore, any effort to increase telehealth support for clinicians should be accompanied by initiatives to address barriers to telehealth for rural, underserved communities.